Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions

AEG Osman, MW Deininger - Blood reviews, 2021 - Elsevier
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by a reciprocal
translocation [t (9; 22)(q34; q11. 2)] that leads to the fusion of ABL1 gene sequences (9q34) …

[HTML][HTML] The Philadelphia chromosome in leukemogenesis

ZJ Kang, YF Liu, LZ Xu, ZJ Long, D Huang… - Chinese journal of …, 2016 - Springer
The truncated chromosome 22 that results from the reciprocal translocation t (9; 22)(q34;
q11) is known as the Philadelphia chromosome (Ph) and is a hallmark of chronic myeloid …

[HTML][HTML] Natural course and biology of CML

B Chereda, JV Melo - Annals of hematology, 2015 - Springer
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder arising in the
haemopoietic stem cell (HSC) compartment. This disease is characterised by a reciprocal t …

[HTML][HTML] Chronic myeloid leukemia: mechanisms of blastic transformation

D Perrotti, C Jamieson, J Goldman… - The Journal of clinical …, 2010 - Am Soc Clin Investig
The BCR-ABL1 oncoprotein transforms pluripotent HSCs and initiates chronic myeloid
leukemia (CML). Patients with early phase (also known as chronic phase [CP]) disease …

[HTML][HTML] Chronic myeloid leukaemia as a model of disease evolution in human cancer

JV Melo, DJ Barnes - Nature Reviews Cancer, 2007 - nature.com
Chronic myeloid leukaemia (CML) can be considered as a paradigm for neoplasias that
evolve through a multi-step process. CML is also one of the best examples of a disease that …

Src homology 2 domain–containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic …

S Costinean, SK Sandhu, IM Pedersen… - Blood, The Journal …, 2009 - ashpublications.org
We showed that Eμ-MiR-155 transgenic mice develop acute lymphoblastic leukemia/high-
grade lymphoma. Most of these leukemias start at approximately 9 months irrespective of the …

[HTML][HTML] Mechanisms of disease progression and resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update

L Bavaro, M Martelli, M Cavo, S Soverini - International journal of …, 2019 - mdpi.com
Chronic myeloid leukemia (CML) is characterized by the presence of the BCR-ABL1 fusion
gene, which encodes a constitutive active tyrosine kinase considered to be the pathogenic …

[HTML][HTML] BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution

C Chai, K Sui, J Tang, H Yu, C Yang, H Zhang, SC Li… - Theranostics, 2023 - ncbi.nlm.nih.gov
Rationale: In the bone marrow microenvironment (BMME), mesenchymal stem/stromal cells
(MSCs) control the self-renewal of both healthy and cancerous hematopoietic …

[HTML][HTML] Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage

R Huber, D Pietsch, T Panterodt, K Brand - Cellular signalling, 2012 - Elsevier
Monocyte/macrophages play an important role in orchestrating the immune response. The
present review refers to C/EBPβ, which is a key transcription factor regulating monocytic …

[HTML][HTML] Honokiol induces ferroptosis by upregulating HMOX1 in acute myeloid leukemia cells

X Lai, Y Sun, X Zhang, D Wang, J Wang… - Frontiers in …, 2022 - frontiersin.org
Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high
mortality. Finding a more effective and readily available treatment is of the utmost …